¡Desconecta con la aplicación Player FM !
Ozempic, Wegovy, and Mounjaro’s Potential Effect on Our Patients with Machell Hudson-Hoover!
Fetch error
Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on June 26, 2024 14:11 ()
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 425396762 series 1392716
Weight loss drugs seemingly come and go just as often as fad diets but we might have a change to that. GLP-1 (and now GLP-2 and 3) drugs are currently mainstream and we are seeing drastic changes in our patients health and appearance. But is it all good news or do we have some things to watch out for? Join Machell Hudson-Hoover on this week's Fast Fact episode.
Machell@rdhhealth
982 episodios
Fetch error
Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on June 26, 2024 14:11 ()
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 425396762 series 1392716
Weight loss drugs seemingly come and go just as often as fad diets but we might have a change to that. GLP-1 (and now GLP-2 and 3) drugs are currently mainstream and we are seeing drastic changes in our patients health and appearance. But is it all good news or do we have some things to watch out for? Join Machell Hudson-Hoover on this week's Fast Fact episode.
Machell@rdhhealth
982 episodios
Todos los episodios
×Bienvenido a Player FM!
Player FM está escaneando la web en busca de podcasts de alta calidad para que los disfrutes en este momento. Es la mejor aplicación de podcast y funciona en Android, iPhone y la web. Regístrate para sincronizar suscripciones a través de dispositivos.